| Market Research A to Z | Company Profiles A to Z | Register | Contact Us |
| +44 (0) 203 086 8600 Call us on |
Market |
Healthcare and Medical |
Report Type |
Market Research |
Country |
Australia |
Published |
1 March 2010 |
Number of Pages |
0 |
- |
|
Publisher |
Datamonitor |
File Format |
- |
Introduction
The Top 20 cancer therapy brands in Australia reached sales of about $545m in 2008, growing at a CAGR of 30% since 2005. We forecast this growth to slow down considerably to a CAGR of 5.6% between 2008 and 2018 mainly due to maturing markets and the entry of generics for several key products. Sales of the Top 20 brands are expected to reach a total of $940m in 2018.
Reasons to Purchase
*Identify key opportunities and threats that will impact the Australian oncology market as a whole and the Top 20 in particular
*Quantify the future size and scope of the Top 20 Australian cancer therapies market and predict the performance of its key compounds
*Understand critical success factors in growing and defending cancer brand franchises from new entrants and generics
|
All posts are pre-moderated and must obey the house rules. |
|
Healthcare and Medical Company Profiles contain up to date financial, strategic, operational, SWOT analysis and product information on the activities of thousands of healthcare and medical companies.
Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?
Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).
Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.